Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Acta Haematologica
|
October 22, 2018
A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Boaz Nachmias, Adir Shaulov, Moshe E Gatt, et al.
Leukemia & Lymphoma
|
October 3, 2018
Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia - improved outcomes with similar toxicity
Vipul Sheth, Boaz Nachmias, Sigal Grisariu, et al.
Journal of Clinical Medicine
|
April 12, 2022
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma
Eyal Lebel, Boaz Nachmias, Marjorie Pick, et al.
International Journal of Molecular Sciences
|
September 23, 2022
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia
Shlomzion Aumann, Adir Shaulov, Arnon Haran, et al.
Cancer Medicine
|
November 24, 2021
Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study
Yael Morgenstern, Shlomzion Aumann, Neta Goldschmidt, et al.
Transfusion
|
March 3, 2023
Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease
Adir Shaulov, Deborah Rund, Dvora Filon, et al.
Cancer Research
|
June 25, 2009
The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity
Ihab Abd-Elrahman, Klilah Hershko, Tzahi Neuman, et al.
Oncology Research and Treatment
|
December 9, 2020
Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System Lymphoma
Stav Gazal, Eyal Lebel, Yosef Kalish, et al.
Clinical Nuclear Medicine
|
May 21, 2020
Posttreatment FDG-Avid Splenic Lesions in DLBCL and HD: Clinical and Radiographic Characteristics for Risk Assessment
Boaz Nachmias, Jeremy Godefroy, Eyal Rozenbach, et al.
Frontiers in Immunology
|
February 11, 2025
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin
Itai Falicovich, Boaz Nachmias, Shlomo Elias, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Acta Haematologica
|
October 22, 2018
A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Boaz Nachmias, Adir Shaulov, Moshe E Gatt, et al.
Leukemia & Lymphoma
|
October 3, 2018
Augmented myeloablative conditioning with thiotepa in acute myeloid leukemia - improved outcomes with similar toxicity
Vipul Sheth, Boaz Nachmias, Sigal Grisariu, et al.
Journal of Clinical Medicine
|
April 12, 2022
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma
Eyal Lebel, Boaz Nachmias, Marjorie Pick, et al.
International Journal of Molecular Sciences
|
September 23, 2022
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia
Shlomzion Aumann, Adir Shaulov, Arnon Haran, et al.
Cancer Medicine
|
November 24, 2021
Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study
Yael Morgenstern, Shlomzion Aumann, Neta Goldschmidt, et al.
Transfusion
|
March 3, 2023
Successful treatment with plasma exchange in life-threatening hyperhemolytic syndrome unrelated to sickle cell disease
Adir Shaulov, Deborah Rund, Dvora Filon, et al.
Cancer Research
|
June 25, 2009
The inhibitor of apoptosis protein Livin (ML-IAP) plays a dual role in tumorigenicity
Ihab Abd-Elrahman, Klilah Hershko, Tzahi Neuman, et al.
Oncology Research and Treatment
|
December 9, 2020
Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System Lymphoma
Stav Gazal, Eyal Lebel, Yosef Kalish, et al.
Clinical Nuclear Medicine
|
May 21, 2020
Posttreatment FDG-Avid Splenic Lesions in DLBCL and HD: Clinical and Radiographic Characteristics for Risk Assessment
Boaz Nachmias, Jeremy Godefroy, Eyal Rozenbach, et al.
Frontiers in Immunology
|
February 11, 2025
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin
Itai Falicovich, Boaz Nachmias, Shlomo Elias, et al.
Page
of 6